Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Intermediate
(1R,3S)-3-Amino-cyclopentanol is a versatile synthetic intermediate with a primary role in pharmaceutical synthesis. This compound serves as a crucial building block for the development of various bioactive molecules. Its unique structure enables applications in medicinal chemistry and drug design, facilitating the exploration of novel therapeutic agents. -
Drug Impurity
Edoxaban Impurity 8 is a chemical impurity associated with the anticoagulant drug Edoxaban. This compound is primarily used for analytical and quality control purposes in pharmaceutical research. Its presence and characterization can provide valuable insights into the stability, purity, and overall quality of Edoxaban formulations. -
Drug Impurity
Progesterone impurity 8, also known as Isoprogesterone, is a drug impurity associated with progesterone synthesis. It may exhibit biological activity and is relevant for studies examining drug metabolism, formulation stability, and impurity profiling in pharmaceutical research. This reagent is valuable for quality control and regulatory compliance in the development of progesterone-based therapies. -
Drug Impurity
Cetirizine Impurity 4 is identified as a chemical impurity associated with the antihistamine Cetirizine. As a relevant research compound, it serves as a standard reference for quality control and method validation in pharmaceutical development. Its characterization is essential for ensuring the safety and efficacy of Cetirizine formulations. Researchers utilize this impurity to investigate the stability and metabolism of Cetirizine in various biological matrices. -
Drug Impurity
Sitagliptin impurity 11 is a known impurity associated with Sitagliptin, a DPP-4 inhibitor used in the treatment of type 2 diabetes. This compound can be utilized in the analysis of drug purity and stability, supporting pharmaceutical researchers in quality control and development of Sitagliptin formulations. Its identification and quantification are essential for ensuring compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Levofloxacin impurity 2, also known as Levofloxacin hydroxy acid, is an impurity associated with the antibiotic Levofloxacin. This compound is of particular interest in the assessment of pharmaceutical quality and safety. It is utilized in research for the characterization of drug impurities and for the evaluation of analytical methods in pharmaceutical development. Its identification and quantification play a critical role in ensuring the integrity and compliance of drug formulations. -
Drug Impurity
Salbutamol impurity 5 is a chemical impurity associated with Salbutamol, a bronchodilator primarily used in the treatment of asthma and other respiratory conditions. This impurity is significant for quality control and regulatory compliance in pharmaceutical development. Its analysis can aid in understanding the stability and safety profiles of Salbutamol formulations, contributing to improved therapeutic efficacy in clinical applications. -
Drug Impurity
Tenofovir impurity 17 is a structural impurity related to the anti-HIV drug tenofovir. Its presence is important for quality control and safety assessments in pharmaceutical formulations. This compound is utilized in research focused on the identification and quantification of impurities, aiding in the overall evaluation of drug purity and compliance with regulatory standards. -
Drug Impurity
Tenofovir impurity 9, also known as Tenofovir disoproxil isopropoxycarbonyl, is a recognized impurity associated with the antiviral drug Tenofovir. This compound is utilized primarily in quality control and analytical research to ensure the purity and safety of Tenofovir formulations. It serves as a valuable reference standard for the identification and quantification of impurities in drug development processes. -
Drug Impurity
Cefmetazole impurity 1 is a known impurity of the cephalosporin antibiotic Cefmetazole, primarily serving as a reference compound for quality control and analytical purposes. Its characterization is essential for understanding the impurity profile of Cefmetazole formulations, ensuring compliance with safety and efficacy standards. This compound aids in the development and validation of analytical methods used in drug testing and quality assurance in pharmaceutical research. -
Drug Impurity
Dacomitinib impurity 12 is a known impurity associated with the drug Dacomitinib, a selective irreversible inhibitor of the EGFR tyrosine kinase. This impurity is relevant for quality control and analytical studies in the pharmaceutical development of Dacomitinib. It is utilized in research to assess the purity and stability of the drug compound in various formulations. -
Drug Impurity
Medroxyprogesterone acetate impurity 3 is a known impurity of the synthetic progestin, Medroxyprogesterone acetate. Its presence is relevant for quality control in pharmaceutical formulations and analytical methods, ensuring the purity and safety of the active pharmaceutical ingredient. This impurity may also be used for research applications aimed at understanding the pharmacological profile and safety assessment of Medroxyprogesterone acetate. -
Drug Intermediate
8-Methyl-4-oxo-N,N-dipropyl-4H-thieno[3,2-c]chromene-2-carboxamide serves as a critical drug intermediate in the synthesis of pyruvate kinase inhibitors. This compound is instrumental in the development of therapeutic agents targeting metabolic pathways, particularly in cancer research, where modulation of pyruvate kinase activity may influence tumor growth and survival. Its utility in synthetic biology allows for the exploration of novel treatments aimed at metabolic dysregulation. -
Drug Impurity
Lopinavir impurity 2 is a known impurity of the antiretroviral drug Lopinavir, primarily characterized by its chemical structure and molecular properties. This reagent is critical for analytical studies focusing on drug purity and stability, particularly in the development and quality control of pharmaceutical formulations. Researchers utilize this impurity to investigate its effects on drug efficacy and safety, enhancing the understanding of Lopinavir's pharmacological profile. -
Drug Impurity
(S)-1-(3-Chloro-4-methylphenyl)ethan-1-amine hydrochloride is characterized as a drug impurity. This compound may arise during the synthesis of certain pharmaceuticals and is important for understanding the purity and safety profiles of drug formulations. Its analysis is critical for compliance with regulatory standards and for ensuring the integrity of drug development processes. -
Montelukast Impurity
Dihydro montelukast is an impurity associated with the synthesis of Montelukast sodium. This compound serves as a useful reference standard for quality control and analytical purposes during the production of Montelukast. Its characterization is essential for ensuring the purity and consistency of Montelukast-containing formulations in research and pharmaceutical applications. -
Drug Impurity
Haloperidol impurity 14 is a known impurity of the antipsychotic agent Haloperidol. This compound is essential for quality control and analytical studies, aiding researchers in assessing purity levels and evaluating potential effects on pharmacological properties. It serves as a critical reference standard in the development and refinement of Haloperidol formulations, ensuring compliance with regulatory standards in pharmaceutical research. -
Drug Impurity
Famotidine impurity 1 is a known impurity associated with the pharmaceutical compound Famotidine, which primarily functions as a histamine H2 receptor antagonist. This reagent is utilized in drug quality assessment and purity analyses to ensure the efficacy and safety of Famotidine formulations. Its presence may impact the pharmacological properties and regulatory compliance of the final drug product, making it essential for research applications focused on drug development and testing. -
Drug Impurity
Rivaroxaban impurity 40 is an identified impurity of the anticoagulant Rivaroxaban, which specifically inhibits Factor Xa. This compound is integral for analytical studies and quality control assessments in pharmaceutical research, aiding in the determination of Rivaroxaban's purity and safety profiles. Its characterization is essential for ensuring compliance with regulatory standards in drug development. -
Drug Impurity
Mycophenolate impurity 3 is a known impurity of the immunosuppressant Mycophenolate. This compound is relevant for the pharmaceutical industry, particularly in the quality control and assessment of drug formulations. Researchers can utilize this impurity to ensure the integrity and compliance of Mycophenolate products in clinical and preclinical studies. -
Drug Impurity
Solifenacin impurity 8 is a chemical impurity associated with Solifenacin, a muscarinic receptor antagonist. This impurity is important for quality control assessments during the synthesis of Solifenacin and can be utilized in the analysis of pharmaceutical formulations to ensure the presence of acceptable impurity levels. Research applications include stability studies and the evaluation of purification methods for the active pharmaceutical ingredient. -
Drug Impurity
Febuxostat impurity 10 is a characterized impurity associated with the drug Febuxostat, a selective inhibitor of xanthine oxidase. This compound is used primarily in pharmaceutical research to assess the purity and stability of Febuxostat formulations. Its identification and analysis can assist in understanding the potential impact of impurities on drug efficacy and safety profiles in drug development processes. -
Drug Impurity
Telmisartan impurity 8 is a chemical impurity associated with Telmisartan, an angiotensin II receptor antagonist used in hypertension management. This impurity is relevant for quality control and analytical characterization in drug development and formulation studies. Researchers can utilize Telmisartan impurity 8 to assess the purity and stability of Telmisartan formulations, contributing to regulatory compliance and pharmacokinetic investigations. -
Drug Impurity
Testosterone impurity 8 is a known impurity of testosterone that can occur during synthesis and formulation processes. This compound serves as an important reference standard in the quality assessment and characterization of testosterone-related products. Its identification and quantification are crucial for ensuring the purity and compliance of pharmaceutical preparations containing testosterone. Researchers can utilize this impurity in stability studies and to investigate potential effects on pharmacological activity. -
Drug Impurity
Amlodipine impurity 4, also known as Phthaloyl Amlodipine, is a recognized drug impurity of Amlodipine. It serves as a valuable reference standard in analytical chemistry and quality control, assisting in the identification and quantification of impurities in pharmaceutical formulations. The characterization of this impurity is critical for ensuring the safety and efficacy of Amlodipine-containing medications. -
Drug Impurity
Azilsartan impurity 17 is an analytical standard used in the quality assessment of Azilsartan formulations. This compound serves as a reference material for regulatory and compliance testing in pharmaceutical development. It is crucial for identifying and quantifying impurities that may arise during drug synthesis, ensuring the safety and efficacy of therapeutic products. -
Drug Impurity
Fenirofibrate impurity 5 is a drug impurity associated with Fenirofibrate, a fibrate-class medication primarily used to manage dyslipidemia. This impurity may serve as a critical reference standard for analytical and quality control in pharmaceutical research, particularly in the assessment of purity and safety profiles of Fenirofibrate formulations. Its identification and characterization contribute to the overall understanding of Fenirofibrate’s pharmacological properties and regulatory compliance. -
Drug Impurity
Fesoterodine impurity 1 is a known impurity of the antimuscarinic agent Fesoterodine, which primarily targets muscarinic acetylcholine receptors. This compound is important for quality control and characterization in the synthesis and analysis of Fesoterodine and its derivatives. It serves as a reference standard in research applications related to drug purity assessments and pharmacological studies. -
Drug Impurity
Olanzapine impurity 3 is a chemical impurity associated with the antipsychotic drug Olanzapine. This compound is primarily utilized in pharmaceutical research for quality control and validation processes, ensuring the integrity and safety of Olanzapine formulations. Its identification and quantification assist in understanding the pharmacological profile and potential effects of the drug, contributing to the overall assessment of drug safety and efficacy. -
Drug Impurity
Levetiracetam Impurity B is a chemical impurity associated with Levetiracetam, a medication primarily used in the management of epilepsy. This compound serves as a reference standard for quality control and analytical testing in pharmaceutical research. It is critical for evaluating the purity and consistency of Levetiracetam formulations in developmental studies and regulatory submissions. -
Drug Impurity
Everolimus impurity 9 is a chemical impurity associated with the immunosuppressant drug Everolimus. This impurity can be utilized for quality control and analytical purposes in pharmaceutical research to ensure the purity and efficacy of drug formulations. Its presence in samples may influence the overall pharmacological profile, making it an important consideration in drug development and safety assessments. -
Drug Impurity
Cannabigerobutol (CBGB) is identified as an impurity related to the cannabinoid cannabigerol. Due to its structural similarities, it may exhibit biological activities that contribute to the pharmacological profile of cannabinoid products. Research applications include the study of cannabinoid metabolism and the effects of impurities on the efficacy and safety of cannabinoid-based therapies. -
Drug Impurity
Telmisartan impurity 14 is a chemical impurity associated with the antihypertensive drug Telmisartan. As a drug impurity, it is important for method validation and quality control in pharmaceutical development. This compound is essential for ensuring adherence to regulatory standards and assessing the purity of Telmisartan formulations. Utilization of Telmisartan impurity 14 is critical in research applications focused on drug safety and efficacy. -
Drug Intermediate
7-Methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-amine serves as a key synthetic intermediate in pharmaceutical synthesis. Its unique structure enables specific modifications, making it integral in the development of compounds aimed at various therapeutic applications. This reagent is essential for researchers working on imidazoquinazoline derivatives and their biological activity within drug discovery frameworks. -
Drug Impurity
Fenirofibrate impurity 6, also known as Fenirofibrate impurity D, is a drug impurity associated with the pharmaceutical compound Fenirofibrate. This impurity may be relevant for qualitative analysis and stability testing within pharmaceutical formulations. Researchers can utilize this compound to better understand the purity and safety profiles of Fenirofibrate during drug development processes. -
Drug Impurity
Aripiprazole impurity 33 is a chemical impurity associated with the antipsychotic drug Aripiprazole. This compound is relevant for pharmaceutical research and quality control, particularly in the assessment of drug purity and safety profiles. Its identification and quantification can aid in the development and validation of analytical methods for ensuring compliance with regulatory standards in drug development. -
Drug Impurity
Albendazole impurity 10 is a synthetic impurity associated with the anthelmintic compound Albendazole. It serves as a critical reference standard for analytical and quality control applications, enabling the identification and quantification of impurities in pharmacological formulations. This reagent is essential for ensuring the purity and efficacy of Albendazole in various research and clinical settings. -
Drug Impurity
Rosuvastatin impurity 28 is a identified impurity of Rosuvastatin, a potent HMG-CoA reductase inhibitor. This compound is essential for assessing the purity and quality of Rosuvastatin in pharmaceutical formulations. Its analysis is crucial for regulatory compliance and research applications related to drug development and quality control in the pharmaceutical industry. -
Drug Impurity
Febuxostat impurity 50 is a characterized impurity of Febuxostat, a selective xanthine oxidase inhibitor. This compound is crucial for analytical chemists in the assessment of drug purity and stability. It serves as a standard reference for quality control and method development in pharmaceutical research involving hypoxanthine and purine metabolism. -
Drug Impurity
Dabigatran impurity 52 is a drug impurity associated with Dabigatran, a direct thrombin inhibitor. This compound is primarily utilized for quality control and analytical studies in pharmaceutical research. Its characterization is essential for ensuring the safety and efficacy of therapeutic formulations containing Dabigatran. -
Drug Impurity
Ciprofloxacin impurity 9, also known as Formyl Ciprofloxacin, is a recognized impurity of the antibiotic ciprofloxacin. Its characterization is crucial for quality control and regulatory compliance in pharmaceutical development. This compound is used in research applications focusing on the assessment of drug purity, stability studies, and the investigation of potential metabolites in ciprofloxacin synthesis. -
Drug Impurity
Olmesartan impurity 12 is a chemical impurity associated with the antihypertensive agent Olmesartan, which primarily targets the angiotensin II receptor. This impurity is vital for analytical research in pharmacokinetics and can be utilized in the assessment of the purity of Olmesartan formulations. Its identification and quantification are essential for regulatory compliance and quality control in pharmaceutical development. -
Drug Impurity
Hydroxychloroquine impurity 2 is a chemical impurity associated with Hydroxychloroquine, an antimalarial and autoimmune disease therapeutic agent. This reagent is essential for analytical studies and quality control in pharmaceutical research, facilitating the evaluation of drug purity and safety. Its characterization plays a crucial role in the development and compliance of medicinal formulations containing Hydroxychloroquine. -
Drug Impurity
Dasatinib impurity 4, also known as Deschloro Dasatinib, is a known impurity associated with the anticancer drug Dasatinib. It serves as a valuable reference standard for analytical studies and quality control in pharmaceutical research. This compound is essential for evaluating the purity and safety of Dasatinib formulations, contributing to the development of effective cancer therapies. -
Drug Impurity
Bumetanide impurity 3 is a known impurity associated with the loop diuretic compound Bumetanide. This compound is primarily used in the evaluation of drug purity and quality control in pharmaceutical formulations. Its characterization is essential for adhering to regulatory standards and ensuring the efficacy and safety of Bumetanide-based therapies. -
Drug Impurity
Apixaban impurity 22 is a characterized impurity associated with the anticoagulant drug Apixaban. Its presence can be critical for quality control in pharmaceutical formulations and analytical research. This reagent is utilized in the study of drug synthesis processes and stability, ensuring the purity and safety of Apixaban in various applications. -
Impurity reference
ent-Abacavir serves as an impurity reference in chemical research. It is an enantiomer of Abacavir, which functions as a competitive nucleoside reverse transcriptase inhibitor. This compound is crucial for studies focusing on the pharmacology and quality control of antiretroviral therapies, specifically in elucidating the effects of chiral centers in drug metabolism and efficacy. -
Drug Impurity
Edoxaban impurity 5 is a chemical impurity associated with the anticoagulant Edoxaban. This impurity is crucial for analytical and quality control applications in pharmaceutical research, particularly in assessing the purity and stability of Edoxaban formulations. Its characterization aids in understanding the compound's behavior and potential impacts on drug efficacy and safety. -
Drug Impurity
Rufinamide impurity 2 is a known impurity associated with the antiepileptic drug Rufinamide. This compound is important for analytical chemistry applications, particularly in the characterization and quality control of pharmaceutical products containing Rufinamide. The study of its properties and behavior may aid in understanding the overall stability and safety profiles of the drug formulation. -
Drug Intermediate
8-Isoquinoline methanamine hydrochloride is a synthetic compound primarily utilized as a drug intermediate in pharmaceutical synthesis. This reagent is critical for the development of various bioactive molecules, enabling the production of novel therapeutic agents. Its utility in organic synthesis positions it as an essential component in the advancement of chemical research and drug discovery efforts.
